Skip to content

Acute Myeloid Leukemia C0023467

Published: July 22, 2026Updated: August 20, 2026

A blood and bone marrow cancer where the body makes too many abnormal white blood cells. It can affect both children and adults, though it's more common in older adults. Treatment includes chemotherapy, targeted therapy, and sometimes stem cell transplant.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C92.60, C92.61, C92.62
ICD-11
2A00.0
Body system
hematologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

!

Sudden weakness

Shortness of breath

(hematologic)

Petechiae

(hematologic)

Bone pain

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Minimally invasive procedural intervention

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
2

Standard '7+3' Induction Therapy

Foundation of AML treatment combining cytarabine and an anthracycline antibiotic over seven and three days respectively to achieve first complete remission.

medication
3

Allogeneic Stem Cell Transplant

Transplantation of healthy donor stem cells after myeloablative conditioning, the most effective post-remission strategy for eligible patients with high-risk features.

procedure

Additional treatment options

Consolidation Chemotherapy

Post-remission chemotherapy using intermediate or high-dose cytarabine to prevent relapse by eliminating remaining leukemic cells undetectable by standard methods.

medication

Molecular Monitoring and Risk Stratification

Regular assessment of measurable residual disease using molecular markers to guide treatment intensity and identify impending relapse early.

monitoring

Integrative Supportive Care

Complementary approaches including acupuncture for chemotherapy-induced nausea, gentle exercise programs, and psychological support to improve treatment tolerance and quality of life.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloid Leukemia C0023467?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2022 ELN recommendations. Blood. 2022;139(1):28-51.

guideline2022View source →
2

Perl AE, Martinelli G, Cortes JE, et al. Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML. N Engl J Med. 2019;381(18):1728-1740.

clinical_trial2019View source →
3

Wei AH, Stroup C, Watts JM, et al. Risk stratification in acute myeloid leukemia: a meta-analysis of chromosomal abnormalities and molecular markers. J Clin Oncol. 2021;39(15_suppl):7020.

meta_analysis2021View source →
4

Khwaja A, Bjorkholm M, Gale RE, et al. Acute myeloid leukaemia. Nat Rev Dis Primers. 2023;2(1):16011.

review2023View source →

Medication Comparisons

Compare medications used to treat Acute Myeloid Leukemia C0023467. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy